Publication:
Use of advanced magnetic resonance imaging techniques in neuromyelitis optica spectrum disorder

dc.contributor.authorStephane Kremeren_US
dc.contributor.authorFelix Renarden_US
dc.contributor.authorSophie Acharden_US
dc.contributor.authorMarco A. Lana-Peixotoen_US
dc.contributor.authorJacqueline Palaceen_US
dc.contributor.authorNasrin Asgarien_US
dc.contributor.authorEric C. Klawiteren_US
dc.contributor.authorSilvia N. Tenembaumen_US
dc.contributor.authorBrenda Banwellen_US
dc.contributor.authorBenjamin M. Greenbergen_US
dc.contributor.authorJeffrey L. Bennetten_US
dc.contributor.authorMichael Levyen_US
dc.contributor.authorPablo Villosladaen_US
dc.contributor.authorAlbert Saizen_US
dc.contributor.authorKazuo Fujiharaen_US
dc.contributor.authorKoon Ho Chanen_US
dc.contributor.authorSven Schipplingen_US
dc.contributor.authorFriedemann Paulen_US
dc.contributor.authorHo Jin Kimen_US
dc.contributor.authorJerome De Sezeen_US
dc.contributor.authorJens T. Wuerfelen_US
dc.contributor.authorPhilippe Cabreen_US
dc.contributor.authorRomain Marignieren_US
dc.contributor.authorThomas Tedderen_US
dc.contributor.authorDanielle Van Pelten_US
dc.contributor.authorSimon Broadleyen_US
dc.contributor.authorTanuja Chitnisen_US
dc.contributor.authorDean Wingerchuken_US
dc.contributor.authorLekha Panditen_US
dc.contributor.authorMaria Isabel Leiteen_US
dc.contributor.authorMetha Apiwattanakulen_US
dc.contributor.authorIngo Kleiteren_US
dc.contributor.authorNaraporn Prayoonwiwaten_US
dc.contributor.authorMay Hanen_US
dc.contributor.authorKerstin Hellwigen_US
dc.contributor.authorKatja Van Herleen_US
dc.contributor.authorGareth Johnen_US
dc.contributor.authorD. Craig Hooperen_US
dc.contributor.authorIchiro Nakashimaen_US
dc.contributor.authorDouglas Satoen_US
dc.contributor.authorMichael R. Yeamanen_US
dc.contributor.authorEmmanuelle Waubanten_US
dc.contributor.authorScott Zamvilen_US
dc.contributor.authorOlaf Stüveen_US
dc.contributor.authorOrhan Aktasen_US
dc.contributor.authorTerry J. Smithen_US
dc.contributor.authorAnu Jacoben_US
dc.contributor.authorKevin O'Connoren_US
dc.contributor.otherUniversitat Gottingenen_US
dc.contributor.otherUniversity of Oxforden_US
dc.contributor.otherMassachusetts General Hospitalen_US
dc.contributor.otherUT Southwestern Medical Schoolen_US
dc.contributor.otherTohoku University School of Medicineen_US
dc.contributor.otherCentre Hospitalier Universitaire de Fort de Franceen_US
dc.contributor.otherCHU de Lyonen_US
dc.contributor.otherDuke University School of Medicineen_US
dc.contributor.otherErasmus University Medical Centeren_US
dc.contributor.otherGriffith Universityen_US
dc.contributor.otherMayo Clinic Scottsdale-Phoenix, Arizonaen_US
dc.contributor.otherNitte Universityen_US
dc.contributor.otherPrasat Neurological Instituteen_US
dc.contributor.otherRuhr-Universitat Bochumen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherStanford University School of Medicineen_US
dc.contributor.otherSt. Josef-Hospital im Katholischen Klinikum Bochumen_US
dc.contributor.otherThe GJCFen_US
dc.contributor.otherThe Mount Sinai Hospitalen_US
dc.contributor.otherThomas Jefferson Universityen_US
dc.contributor.otherUniversity of California, Los Angelesen_US
dc.contributor.otherUniversity of California, San Franciscoen_US
dc.contributor.otherHeinrich Heine Universitaten_US
dc.contributor.otherUniversity of Michigan, Ann Arboren_US
dc.contributor.otherWalton Centeren_US
dc.contributor.otherYale University School of Medicineen_US
dc.contributor.otherUniversite de Strasbourgen_US
dc.contributor.otherCHU Strasbourgen_US
dc.contributor.otherCNRS Centre National de la Recherche Scientifiqueen_US
dc.contributor.otherUniversidade Federal de Minas Geraisen_US
dc.contributor.otherSyddansk Universiteten_US
dc.contributor.otherVejle Sygehusen_US
dc.contributor.otherNational Pediatric Hospital Dr. Juan P. Garrahanen_US
dc.contributor.otherUniversity of Pennsylvaniaen_US
dc.contributor.otherThe Children's Hospital of Philadelphiaen_US
dc.contributor.otherUniversity of Colorado Health Sciences Centeren_US
dc.contributor.otherJohns Hopkins Universityen_US
dc.contributor.otherHospital Clinic Barcelonaen_US
dc.contributor.otherThe University of Hong Kongen_US
dc.contributor.otherUniversitatsSpital Zurichen_US
dc.contributor.otherUniversity Hospital Zurich Neurologische Kliniken_US
dc.contributor.otherTechnical High Schoolen_US
dc.contributor.otherUniversity of Zurichen_US
dc.contributor.otherCharité – Universitätsmedizin Berlinen_US
dc.contributor.otherResearch Instituteen_US
dc.contributor.otherNational Cancer Center, Gyeonggien_US
dc.contributor.otherInsermen_US
dc.date.accessioned2018-11-23T10:42:02Z
dc.date.available2018-11-23T10:42:02Z
dc.date.issued2015-07-01en_US
dc.description.abstractCopyright 2015 American Medical Association. All rights reserved. Brain parenchymal lesions are frequently observed on conventional magnetic resonance imaging (MRI) scans of patients with neuromyelitis optica (NMO) spectrum disorder, but the specific morphological and temporal patterns distinguishing them unequivocally from lesions caused by other disorders have not been identified. This literature review summarizes the literature on advanced quantitative imaging measures reported for patients with NMO spectrum disorder, including proton MR spectroscopy, diffusion tensor imaging, magnetization transfer imaging, quantitative MR volumetry, and ultrahigh-field strength MRI. It was undertaken to consider the advanced MRI techniques used for patients with NMO by different specialists in the field. Although quantitative measures such as proton MR spectroscopy or magnetization transfer imaging have not reproducibly revealed diffuse brain injury, preliminary data from diffusion-weighted imaging and brain tissue volumetry indicate greater white matter than gray matter degradation. These findings could be confirmed by ultrahigh-field MRI. The use of nonconventional MRI techniques may further our understanding of the pathogenic processes in NMO spectrum disorders and may help us identify the distinct radiographic features corresponding to specific phenotypic manifestations of this disease.en_US
dc.identifier.citationJAMA Neurology. Vol.72, No.7 (2015), 815-822en_US
dc.identifier.doi10.1001/jamaneurol.2015.0248en_US
dc.identifier.issn21686149en_US
dc.identifier.other2-s2.0-84937548674en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/36399
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84937548674&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleUse of advanced magnetic resonance imaging techniques in neuromyelitis optica spectrum disorderen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84937548674&origin=inwarden_US

Files

Collections